FORMER SENIOR FBI OFFICIAL LOUIS E. GREVER JOINS INTEGENX BOARD OF DIRECTORS
March 28, 2012
PLEASANTON, Calif. – IntegenX Inc., a privately held company that is leading the emerging field of rapid human DNA identification, today announced that Louis E. Grever, former Executive Assistant Director, Science and Technology Branch of the Federal Bureau of Investigation (FBI), has joined the company’s Board of Directors. “Rapid DNA analysis is a transformative technology [...]
March 28, 2012
A microsite dedicated to the natural resource industries has been launched today by Carl Zeiss. The sustainable use of natural resources is dependent upon improving the efficiency of the mining, refining and end production industries. The new microsite from Carl Zeiss addresses the challenges for natural resource industries and demonstrates how pioneering microscopy solutions can [...]
March 28, 2012
Qlucore, a world leader in the development of bioinformatics software, has today announced an agreement with Filgen, Inc, one of Japan's leading specialists in sales of science research equipment. Since its launch in 2004, Filgen has earned an international reputation for its work within the biotechnology and pharmaceutical sectors, including its highly regarded Biotechnology Analysis [...]
March 28, 2012
SANTA FE SPRINGS, Calif -- Applied BioCode announced today that it has signed a license agreement for its Barcoded Magnetic Bead (BMB) technology with Alexandria, Minnesota based Douglas Scientific. This non-exclusive license will give Douglas Scientific access to specific Applied BioCode BMB patents for the development of an ultra high throughput automation platform for use [...]
March 28, 2012
PRINCETON, N.J. & GAITHERSBURG, Md. -- Bristol-Myers Squibb Company (NYSE:BMY) and Meso Scale Discovery today announced they have entered an agreement to develop diagnostic assays that will measure cerebrospinal fluid biomarkers for use in Alzheimer’s disease research. Under the terms of the agreement, the companies will develop these assays based on the Meso Scale Discovery® [...]
RainDance Technologies Powers Autism Screening Panel Launched by Greenwood Genetic Center
March 28, 2012
LEXINGTON, Mass. AND CHARLOTTE, N.C.,– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that Greenwood Genetic Center has commercially launched its Syndromic Autism 62-Gene Panel which was built for use on RainDance’s picodroplet-based targeted sequencing platform. The panel sequences 62 individual autosomal and X-linked genes that represent the most common single gene etiologies associated [...]
March 28, 2012
Stockholm, Sweden - March 28, 2012 - LingVitae, Plarion Ltd and KTH Royal Institute of Technology have today announced engagement into a collaborative development program aiming at utilising the new Discipher system for bringing DNA-based testing and diagnostics to point-of-care settings. “Our aim with the Discipher is to democratise molecular and cellular analysis, putting low-cost [...]
IDBS Delivers Platform to Accelerate Personalized Cancer Care at King’s Health Partners
March 28, 2012
London, UK, and Boston,- IDBS, a global provider of innovative data management, analytics and modeling solutions, today announced that King’s Health Partners has deployed the Oncology Research Information System (ORIS). The ground-breaking platform is the first of its kind in production and consolidates translational medicine data from multiple sites into one system. ORIS will help [...]
Tecan publishes 2011 Annual Report and notice of its Annual General Meeting
March 28, 2012
Männedorf, Switzerland, - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2011 Annual Report in the Investor Relations section of the company's website at www.tecan.com. Tecan already published its 2011 financial results in a press release and at the Press Briefing on Annual Results and Analysts' Conference held on March [...]
Innovaro Announces Completion of Licensing Agreement between Inven2 and Oxford Gene Technology
March 28, 2012
Tampa, FL – Innovaro, Inc (NYSE Amex: INV), The Innovation Solutions Company, is pleased to announce that its client Inven2, the technology transfer office at Oslo University Hospital and University of Oslo, has entered into an exclusive licensing agreement with Oxford Gene Technology (OGT) for 12 highly promising colorectal cancer tissue biomarkers through Innovaro’s Pharmalicensing [...]

